Evidence map›Paper›PMID 39460031›Full record

ArticleSensors (Basel, Switzerland)2024

A Microbial Cocaine Bioreporter.

Anne-Kathrin Grimm, Dor Rozanes, Etai Shpigel, Liat Moscovici, Shimshon Belkin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Sensors (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anne-Kathrin GrimmInstitute of Analytical Chemistry, Chemo- and Biosensors, University of Regensburg, 93053 Regensburg, Germany.ORCID 0009-0004-7239-7438
Dor RozanesInstitute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.
Etai ShpigelInstitute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.
Liat MoscoviciInstitute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.
Shimshon BelkinInstitute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.ORCID 0000-0001-8283-1673

Funding

Minerva Stiftung Minerva Center for Biohybrid Complex Systems
6 · The paper itself

Abstract

The continuous emergence of new illegal compounds, particularly psychoactive chemicals, poses significant challenges for current drug detection methods. Developing new protocols and kits for each new drug requires substantial time, effort, and dedicated manpower. Whole-cell bacterial bioreporters have been proven capable of detecting diverse hazardous compounds in both laboratory and field settings, identifying not only single compounds but also chemical families. We present the development of a microbial bioreporter for the detection of cocaine, the nervous system stimulant that is the second-most widely used illegal drug in the US.

Indexed as

Biosensing TechniquesCocaineEscherichia coliHumansPlasmidsPromoter Regions, GeneticCocaineben operonbioluminescencecocainecocaine esteraseEscherichia colimicrobial bioreportersPseudomonas putida

Identifiers

PMID39460031
PMCPMC11511522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.